How do I buy SELLAS Life Sciences Group, Inc. Common Stock (SLS) stock?

Buying SELLAS Life Sciences Group, Inc. Common Stock (SLS) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "SLS", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy SLS by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if SLS is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

SELLAS Life Sciences Group, Inc. Common Stock (SLS) Stock

Q: What is the minimum investment for SLS on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in SELLAS Life Sciences Group, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · SLS

Trade SLS

Key stats

Market cap: $1.70B
Price / Earnings ratio: -52.1x
EPS (TTM): -$0.21
Volume: Loading
52-week high: $15.88
52-week low: $1.39

Source: third-party data provider, as of November 13, 2026

Compare with SLS

Technical indicators

RSI 14: 37.60
MACD 12/26/9: -0.91
EMA 9 of MACD: -0.74
MACD histogram: -0.17
SMA 50: $11.27; Price below SMA 50
EMA 50: $10.75; Price below EMA 50
SMA 200: $8.74; Price below SMA 200
EMA 200: $8.38; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

No analyst data available

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

9M6M3M0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

94M62M31M0

Revenue to Profit

2025

$0.0

Revenue

$0.0

Cost of revenue

$0.0

Gross profit

$0.0

Operating expenses

$-26.9M

Net income

Earnings

No data available

Source: third-party data provider

About SELLAS Life Sciences Group, Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees13

CEODr. Angelos M. Stergiou M.D., ScD h.c.

IPO DateDec 29, 2017

HeadquartersNew York, NY

Key Executives

Name	Title	Year Born
Dr. Angelos M. Stergiou M.D., ScD h.c.	Founder, President, CEO & Director	1976
Mr. John Thomas Burns CPA	Senior VP & CFO	1985
Dr. Dragan Cicic M.D., MBA	Senior VP & Chief Development Officer	1963
Ms. Stacy E. Yeung	VP, General Counsel & Corporate Secretary	—
Mr. Andrew Elnatan	Senior VP of Regulatory Affairs, CMC & Quality	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-9.8	-12.1
2022	-8.9	+9.9	+9.2	-34.5	+7.0	-20.4	+16.4	+21.9	-33.3	+131.7	-50.3	-9.2
2023	+30.2	-48.8	-8.9	-13.0	+15.4	-7.1	+5.8	-10.4	+9.3	-38.2	+9.5	-1.9
2024	-28.9	+68.3	+1.0	+15.9	+10.2	-16.2	-1.7	+4.0	-0.8	-2.5	-5.0	-10.3
2025	+51.4	-20.3	-6.9	+42.2	+5.6	+38.6	-23.6	+15.7	-12.0	+7.7	-9.5	+151.3
2026	-13.3	+24.2	-16.2	+17.6	+88.8	+62.7	-24.6	+18.9	-6.9	-14.6	-1.5

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying SELLAS Life Sciences Group, Inc. Common Stock (SLS) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "SLS", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy SLS by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in SELLAS Life Sciences Group, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, SELLAS Life Sciences Group, Inc. Common Stock (SLS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track SLS's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

SELLAS Life Sciences Group, Inc. Common Stock (SLS) Stock

Key stats

Compare with SLS

Recent news

CAPR vs IBRX vs SLS vs IOVA: Whose Insiders Cashed Out The Most — And Who Bought Before A 5X Surge?

CAPR vs IBRX vs SLS vs IOVA: Whose Insiders Cashed Out The Most — And Who Bought Before A 5X Surge?

SLS Stock Rises After-Hours: State Street Reveals Over 5% Stake — And One Fund Manager Boosted Holdings By Nearly 1,000%

SLS Stock Rises After-Hours: State Street Reveals Over 5% Stake — And One Fund Manager Boosted Holdings By Nearly 1,000%

SLS Stock Rises Overnight: Retail Bets The Regal Wait Is Almost Over — Here’s What Wall Street Expects From Earnings

SLS Stock Rises Overnight: Retail Bets The Regal Wait Is Almost Over — Here’s What Wall Street Expects From Earnings

SLS Stock Rises Overnight Despite Citi’s 64% Stake Cut — Retail Bulls Say SLS009 Alone Could Outvalue Sellas

SLS Stock Rises Overnight Despite Citi’s 64% Stake Cut — Retail Bulls Say SLS009 Alone Could Outvalue Sellas

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

CAPR vs IBRX vs SLS vs IOVA: Whose Insiders Cashed Out The Most — And Who Bought Before A 5X Surge?

CAPR vs IBRX vs SLS vs IOVA: Whose Insiders Cashed Out The Most — And Who Bought Before A 5X Surge?

SLS Stock Rises After-Hours: State Street Reveals Over 5% Stake — And One Fund Manager Boosted Holdings By Nearly 1,000%

SLS Stock Rises After-Hours: State Street Reveals Over 5% Stake — And One Fund Manager Boosted Holdings By Nearly 1,000%

SLS Stock Rises Overnight: Retail Bets The Regal Wait Is Almost Over — Here’s What Wall Street Expects From Earnings

SLS Stock Rises Overnight: Retail Bets The Regal Wait Is Almost Over — Here’s What Wall Street Expects From Earnings

SLS Stock Rises Overnight Despite Citi’s 64% Stake Cut — Retail Bulls Say SLS009 Alone Could Outvalue Sellas

SLS Stock Rises Overnight Despite Citi’s 64% Stake Cut — Retail Bulls Say SLS009 Alone Could Outvalue Sellas

Sellas To Present SLS009 Data At American Society of Hematology – Initial Results Of Therapy In Newly Diagnosed AML Patients Expected In Q4

Sellas To Present SLS009 Data At American Society of Hematology – Initial Results Of Therapy In Newly Diagnosed AML Patients Expected In Q4

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Hits Over 1-Month Low: Retail Bulls Double Down Before Cancer Data — Fresh Filings Show Q3 Stake Hikes Of Over 400%

SLS Stock Hits Over 1-Month Low: Retail Bulls Double Down Before Cancer Data — Fresh Filings Show Q3 Stake Hikes Of Over 400%

SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus

SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus

SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3

SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3

Dow, S&P 500, Nasdaq Futures Fall As Weak Tech Earnings Trigger Selloff: INTC, IOVA, SLS, AMZN Stocks In Focus

Dow, S&P 500, Nasdaq Futures Fall As Weak Tech Earnings Trigger Selloff: INTC, IOVA, SLS, AMZN Stocks In Focus

About SELLAS Life Sciences Group, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade